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1. Introduction 
It is estimated that 2.1 million married couples or 5 million people in the United States are 
affected by infertility.1 Infertility is defined as failure to get pregnant after one year of 
unprotected intercourse. About 40% of infertility cases are due to a female factor and 40% 
due to a male factor. The remaining 20% are the result of a combination of male and female 
factors, or are of unknown causes.2 Issues of human infertility are extremely complex 
physiologically, psychologically, financially, legally and ethically. It is estimated that 85-90% 
of infertile couples will receive conventional treatment and 10-15% may become candidates 
for various forms of Assisted Reproductive Technologies (ARTs) to assist them in having 
their own biological children. In-vitro fertilization (IVF) is one of the most utilized 
reproductive procedures that has allowed couples to have their own biological children. IVF 
accounts for 99% of ART. This procedure has been effective but it is still inefficient and 
expensive. One aspect of the inefficiency is that numerous embryos have been frozen 
through a process called cryopreservation. It has been estimated that there are 400,000 
embryos frozen and stored since the late 1970s.3 In reality, the actual number of frozen 
embryos is probably closer to 500,000 with an additional 20,000 embryos added yearly.4  
Freezing these embryos has allowed for a limitation on the number of embryos transferred 
to a woman’s uterus which has decreased the number of multiple gestations. It also allows 
couples to use the frozen embryos in the future if the initial cycles are unsuccessful. This is 
not only more effective but also lowers the cost. The issue is now what to do with the 
400,000 to 500,000 frozen embryos that remain as “spares.” Various alternatives have been 
suggested. The embryos could be thawed and then destroyed, continued to be 
cryopreserved indefinitely, used for research, or offered for donation/adoption. All of these 
options present problems medically, legally and ethically, especially for Roman Catholics.  
Medically, the lifespan of a cryopreserved embryo is unknown. The effect of the freezing 
process is also unknown on the quality of the embryo if brought to term. “Studies have 
found that babies created through IVF are twice as likely to be born underweight and with 
major birth defects.”5 With the unknown effects of cryopreservation on embryo 
development the medical issues become even more complex. Legally, only 2% of frozen 
embryos are specifically designated for donation/adoption and 5% are specifically 
designated for destruction or research.6 The legal issues focus on the applicability of contract 
law versus family law because frozen embryos are technically considered “property” not 
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“persons.” Presently, the applicability of contract law or family law remains unclear. In 
addition, to date only three states—Florida, Louisiana and New Hampshire—have adopted 
legislation concerning the disposition or disposal of embryos. Legally and legislatively the 
issue of embryo donation/adoption is ambiguous at best. Ethically, depending on one’s 
view of when personhood begins, frozen embryos may be considered human persons, 
which deserve dignity and respect, or they may have less than human status with no 
particular ethical rights. From an ethical perspective that views personhood beginning at 
fertilization, one could argue that the “rescue” of these embryos could be considered 
ethically acceptable. The problem is that in 2008 the Vatican’s Congregation for the Doctrine 
of the Faith issued an Instruction called  Dignitas Personae, which stated that prenatal 
adoption, “praiseworthy with regard to intention of respecting and defining human life, 
presents however various problems” and is considered unethical.7 If donation/adoption is 
not acceptable by the Magisterium then the only remaining option would be to stop the 
process of cryopreservation and allow the thawed embryos to die with dignity and respect 
under the principle of the extraordinary/ordinary means distinction.  
This article will focus on allowing to die under the principle of extraordinary/ordinary 
means distinction as a viable option to address the 400,000 to 500,000 frozen embryos in the 
United States. The intended purpose of this article is threefold: first, to examine the medical 
issues surrounding the cryopreservation of frozen embryos; second, to give an ethical 
analysis of the arguments for and against allowing to die; and third, to give 
recommendations on how to avoid the continuation of this problem in the future. 
2. Medical aspects 
Infertility is a major problem for many couples in the United States. “About one married 
couple in 12 cannot conceive a child after two years of trying. Infertility stems from many 
factors, including a woman’s age at the first attempt to conceive, damage from pelvic 
inflammatory disease, previous abortions, uterine abnormalities, and a man’s low sperm 
count or low sperm motility.”8 Individually, male and female factors each account for about 
40% of infertility in the United States. Numerous technologies are available to couples from 
artificial insemination by a husband or a donor, to gamete intrafallopian transfer (GIFT), to 
zygote intrafallopian transfer (ZIFT), to in-vitro fertilization. Of these reproductive 
technologies IVF has become the ART of choice for many infertile couples. IVF is an assisted 
reproductive technology which had its first success in 1978 when Drs. Edwards and Steptoe 
in Oldham, England created the first “test tube baby” named Louise Brown. Since that first 
success, IVF technology has been refined and over 3 million babies have been born 
worldwide.9  
There are five basic steps to IVF. 1) Harvesting the eggs from the woman’s ovaries. The woman’s 
ovaries are hyperstimulated using fertility drugs that produce numerous eggs. During this 
period the woman will have regular transvaginal ultrasounds to examine the ovaries and 
blood tests to check hormone levels. 2) Egg retrieval. The eggs are removed from the 
woman’s body using follicular aspiration. Using ultrasound images as a guide the physician 
inserts a thin needle through the vagina and into the ovary and sacs containing the eggs. 
The needle is connected to a suction device, which pulls the eggs and fluid out of each 
follicle, one at a time. In rare cases, a pelvic laparoscopy may be used to remove the eggs. 3) 
Insemination and Fertilization. The man’s sperm is placed with the best quality eggs in a petri 
www.intechopen.com
 
Cryopreserved Embryos: A Catholic Alternative to Embryonic Stem Cell Research and Adoption 
 
35 
dish and stored in an environmentally controlled chamber. The mixing of the sperm and egg 
is called insemination. The sperm usually enters an egg a few hours after insemination. If 
there is a low chance for fertilization, one single sperm can be injected into an egg in a 
procedure called Intracytoplasmic Sperm Injection (ICSI). 4) Embryo culture. The fertilized 
eggs remain in the petri dish for 48 to 72 hours to verify that the embryo is not defective and 
growing properly. If a couple is at high-risk for passing on genetic (hereditary) disorders to 
a child they may consider using Pre-implantation Genetic Diagnosis (PGD). The procedure 
is performed 3-4 days after fertilization. A single cell is removed from each embryo to screen 
it for specific genetic disorders. Those embryos with the genetic disorder are usually 
destroyed. 5) Embryo transfer. Anywhere from 1-4 embryos are placed in the woman’s womb 
3 to 4 days after fertilization. The physician inserts a thin catheter containing the embryos 
into the woman’s vagina, through the cervix, and up into the womb. If the embryo implants 
in the woman’s uterine wall pregnancy will result.10   
The implantation rate is estimated at 10-25%.11 The overall birth rate varies from 11% 
(women over 40) to about 35% (women under 35).12 This clearly shows that a number of 
embryos transferred fail to survive, which is why multiple embryos are transferred per cycle 
and why numerous cycles are required. On average, 2.7 embryos per cycle are transferred in 
women under 35, with an average of 3 in older women. Depending on the embryo quality, 
up to 5-6 embryos can be transferred.13 The average cost of IVF is $12,000-17,000 per cycle. It 
is estimated that 75% of couples who have tried IVF and who spent from $10,000-100,000 
still go home without a baby.14 Risks include the possibility of ovarian hyperstimulation 
syndrome (OHSS), risks in the egg retrieval stage which include reactions to anesthesia, 
bleeding, infection and damage to structures surrounding the ovaries including the bowel 
and bladder, and finally there are the risks associated with multiple pregnancies. Since 1980 
the rate of twins has climbed 70% to 3.2% of births in 2004. Multiple gestations raise the risk 
of preterm births; low-birth-weight babies, with the possibility of death in very premature 
infants; long-term health problems; and pregnancy complications, which include pre-
eclampsia, gestational diabetes, and Caesarean section. Studies have shown that 56% of IVF 
twins born in 2004 weighed less than 5.5 pounds, and 65% were born prematurely, before 37 
weeks of gestation.15  Embryos not transferred in a fresh IVF cycle are usually 
cryopreserved. Freezing these embryos offers individuals the possibility of transferring the 
frozen embryos for later IVF cycles if the previous cycle does not result in a pregnancy. It is 
also cost effective and eliminates the need to undergo the steps needed for a fresh IVF cycle. 
In most cases the best quality embryos are transferred in the fresh cycle and those of a lesser 
quality are frozen for later transfer. It should be noted that some clinics have individual 
freezing and thawing to achieve the exact number of embryos desired for transfer. This 
procedure avoids embryo wastage.  
 The process of cryopreservation has become an integral part of the IVF procedure. 
“Cryopreservation is a process of freezing biological tissues for storage, while minimizing 
cellular damage from freezing and thawing.”16 This technique entails freezing the embryo 
while simultaneously removing the intracellular water and replacing it with a 
cryoprotectant solution which help to protect the embryo during the freezing process. The 
embryos are then placed into cryopreservation straws or vials, which are labeled with the 
patient’s name, the patient’s IVF number, and the date of the freeze. Once the process is 
complete, the embryos are placed in a computer controlled freezing unit. After the freezing 
run is complete, the straws are stored in a special tank filled with liquid nitrogen at a 
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temperature of minus 196 degrees centigrade.17 Many storage facilities use a back-up system 
to minimize the risk of interruption in the freezing process. Liquid nitrogen containers are 
armed with an automatic alarm system to monitor nitrogen levels and prevent premature 
thawing.18 These embryos are looked upon as being in a state of “suspended animation.” 
Cellular activity has ceased, but each embryo is still alive. When the remaining embryos are 
needed a procedure utilizing rapid thawing and removal of the cryopreservative solution 
with simultaneous rehydration is used. The embryos are first warmed in a 98.6 F degree 
solution and the cryoprotectant chemicals are removed.19 
The embryo thawing process is quite complex. “Embryo survival is based on the number of 
viable cells in an embryo after thawing. An embryo has ‘survived’ if >50% of the cells are 
viable. An embryo is considered to ‘partially survive’ if <50% of its cells are viable and to be 
‘atretic’ if all the cells are dead at thaw. Approximately, 65-70% of embryos survive thaw, 
10% partially survive and 20-25% are atretic. Data suggests that embryos with 100% cell 
survival are almost as good as embryos never frozen but only about 30-35% survive this 
fashion. Embryos that are 2, 4 or 8 cells when frozen have about a 5-10% greater survival 
than embryos with an odd number of cells. Donor egg embryos have a 2-5% greater survival 
rate than embryos from infertile women when compared by morphology score”20 The cost 
of cryopreservation is approximately $600-700 a year. The success rate or pregnancy rate 
depends on numerous factors: the number of surviving embryos transferred, the number of 
100% surviving embryos transferred, and the morphology scores of the transferred embryos. 
The delivered pregnancy rates range from 5% (a single poor quality embryo) to 36% (4 high 
quality embryos) when the cycles from 1987 to 2001 were combined. It is estimated that 
embryo cryopreservation adds about 10-30% more pregnancies per retrieval cycle and the 
outcomes of the children are normal.21 The reason for the wide range of costs and success 
rates is because the Assisted Reproductive Technologies industry in the United States is 
unregulated. The success rates and costs can vary from clinic to clinic and there is no 
government oversight examining the widespread differences. 
The advantages of embryo freezing are numerous: reducing the risks of multiple gestations 
potentially increases pregnancy rates, decreasing the number of stimulated treatment cycles 
needed to achieve pregnancy, decreasing the costs of ARTs, etc. The main disadvantage 
according to the 2003 RAND/SART Working Group study centers on the approximately 
400,000 frozen “spare” embryos stored since the 1970’s.22 More recent numbers have the 
number of frozen embryos in excess of 500,000. The 500,000 number seems more realistic 
considering the increase in IVF procedures since 2003. The issue that is confronting parents 
and fertility clinics is what to do with these “spare” embryos medically, legally and 
ethically.  
The RAND/SART survey in 2003 found that of the 400,000 frozen spare embryos 88.2% 
were designated for family building and 2.8% (11,000) were designated for research. Those 
embryos designated for research could produce as many as 275 stem cell lines (cell cultures 
suitable for further development). However, the number would in reality be much lower. Of 
the remaining embryos, it is estimated that 2.3% (10,000) are awaiting donation, 2.2% are 
designated to be discarded, and 4.5% are held in storage for other reasons, including lost 
contact with a patient, patient death, abandonment, and divorce.23 There are numerous 
issues concerning the “spare” frozen embryos. The ART clinics transfer the highest quality 
embryos (those that grow at a normal rate) to the patient during treatment cycles. The 
remaining embryos are usually designated as not of the highest quality. In addition, some of 
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the frozen embryos have been in storage for many years, and when these embryos were 
created the laboratory cultures were not as conducive to preserving embryos as they are 
today. Some embryos would also die in the freeze-thaw process. Considering all these 
issues, the question is how many embryos actually are available for research and 
donation/adoption?  The RAND/SART team estimated that 65% of the approximately 
11,000 embryos designated for research would survive the freeze-thaw process, resulting in 
7,334 embryos. Of those, about 25% (1,834 embryos) would likely be able to survive the 
initial stages of development to the blastocyst stage (a blastocyst is an embryo that has 
developed for at least 5 days). Even fewer could be converted into embryonic stem cell lines. 
Their estimate is about 275 embryonic stem cell lines could be converted from the total 
number of embryos designated for research. The RAND/SART team also estimates that 
2.3% of the 400,000 frozen “spare” embryos designated for donation/adoption, only 23,000-
100,000 embryos could be adopted, thawed and successfully born.24 Having this many 
children potentially available for adoption would help meet the need of couples seeking 
adoption in the United States. The problem is that the adoption process for frozen embryos 
is legally quite ambiguous and very complex. In addition, with the Magisterium of the 
Catholic Church issuing the Instruction Dignitas Personae it appears that donation/adoption 
is no longer acceptable for Catholics. The only viable option for these spare embryos would 
be to allow them to be thawed and to die with dignity and respect under the principle of 
extraordinary/ordinary. The central issue is whether this is an ethically sound viable 
solution for the Roman Catholic Church.  
3. Ethical aspects 
Ethically, the concern about spare embryos focuses on the issue of personhood. If embryos 
are persons then it would be a moral imperative to “rescue” these embryos from their 
current status of being in “frozen animation.” Numerous ethicists, embryologists, legal 
professionals and specifically, the Roman Catholic Church, argue that personhood begins at 
conception or what is known as fertilization. Prior to fertilization we have two human 
gametes—sperm and egg, that are living but are not a living organism. When fertilization 
occurs, something human and living “in a different sense comes into being.”25 
Embryologists argue that “human development begins at fertilization when a male gamete 
or sperm (spermatozoon) unites with a female gamete or oocyte (ovum) to form a single 
cell—zygote. This highly specialized, totipotent cell marked the beginning of each of us as a 
unique individual.”26 The Catholic Church teaches that “human life must be absolutely 
respected and protected from the moment of conception.”27 “Right from fertilization is 
begun the adventure of a human life, and each of its great capacities requires time . . . to find 
its place and to be in a position to act. This teaching remains valid and is further confirmed, 
if confirmation were needed, by recent findings of human biological science which 
recognize that in the zygote resulting from fertilization the biological identity of a new 
human individual is already constituted.”28 The Church argues that at fertilization there is a 
new genetic individual in its own right, one who is whole, bodily, self-organizing, and 
genetically distinct from his or her mother and father.29 Those who argue that personhood 
begins at fertilization would also argue that there is a moral imperative to give these frozen 
embryos the opportunity to be born and to develop because they are persons. Ethicist 
Therese Lysaught believes that embryo donation/adoption is an act that can properly be 
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described as “rescuing a child orphaned before birth.”30 Ethicists arguing for the “rescue” of 
these children would encourage women to implant these embryos in their wombs in order 
to bring them to term. Some would permit not only married women to do this but also 
single women and even lesbian couples. The moral principle of sanctity of human life would 
overcome any other moral considerations. However, not all, even in the Catholic Church, 
would agree to this ethical analysis. Opponents of this position argue that this would 
amount to material cooperation in an objective immoral action. Not only is the process of 
IVF considered an intrinsic moral evil by the Magisterium of the Catholic Church, but 
allowing for the donation/adoption of these embryos might condone the objective immoral 
procedure and may even encourage the creation of additional embryos through the IVF 
process. The Catholic Church clarified its position on embryo donation/adoption in 2008 in 
the Instruction from the Congregation of the Faith called Dignitas Personae. “The proposal 
that these embryos could be put at the disposal of infertile couples as a treatment for fertility 
is not ethically acceptable for the same reasons which make artificial heterologous 
procreation illicit as well as any form of surrogate motherhood; this practice would also lead 
to other problems of a medical, psychological and legal nature.”31 This statement by the 
Magisterium removes donation/adoption as a viable option for Catholics. The only 
remaining option would be to allow these embryos to die with dignity and respect using the 
extraordinary/ordinary means distinction. To determine if thawing these embryos and 
allowing them to die naturally is ethical and to address the ambiguities and unresolved 
issues surrounding this controversy, the traditional ethical principle of the 
extraordinary/ordinary means distinction will be examined and applied to this situation.  
The history of the Catholic Church’s position on the ordinary-extraordinary means 
distinction dates back to the 16th century Dominican moralists. There are however, some 
who believe it may go back to Thomas Aquinas (1225-1274) a Dominican Friar and Doctor of 
the Roman Catholic Church. Thomas’ belief in the moral measure of all human activity is 
whether it leads to God, the final end. Thus, if something was “too difficult” or “too 
burdensome” what was implied was that it might make loving God too difficult.32   The 
general obligation to preserve life and the possible limits to that obligation are also 
influenced by Thomas’ concept of God’s dominion over the gift of human life, responsible 
stewardship and the positive and negative precepts derived from these.33  Thomas’ 
influence is clearly present, but it is the three Dominican moralists--Francisco De Vitoria, 
Domingo Soto and Domingo Banez--who articulated the foundation of the ordinary-
extraordinary means distinction.  
De Vitoria (1486-1546) examined the limits of treatment in regards to nourishment and 
medicinal drugs. In his seminal work Relectiones Theologicae he states: 
“If a sick man can take food or nourishment with a certain hope of life, he is required to take 
food as he would be required to give it to one who is sick. However, if the depression of 
spirits is so severe and there is present grave consternation in the appetitive power so that 
only with the greatest effort and as though through torture can the sick man take food, this 
is to be reckoned as an impossibility and therefore, he is excused, at least from mortal sin.”34 
De Victoria is not condoning suicide here. A healthy person may not starve him-herself 
because life is problematic. If the means are effective and not burdensome then the person is 
morally obligated to seek nourishment. However, if the person is so sick or depressed that 
eating may become a grave burden, then the person is not morally obliged to eat and does 
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not commit a sin. The essential point here is that De Vitoria recognizes both psychological 
and physiological illness and his notion of grave burden includes both. In regards to 
medicinal drugs, he argues that they are not per se obligatory. The obligation to use them 
rested on the degree of efficacy. One is not obliged to sacrifice one’s whole means of 
subsistence, nor one’s general lifestyle, nor one’s homeland in order to acquire a cure or 
obtain optimum health.35 It appears that De Vitoria adopted the 16th century’s version of the 
“Reasonable Person” criteria. “To fulfill one’s positive obligation to sustain life, it is 
sufficient to perform ‘that by which regularly a man can live.’”36 The moral components that 
appear operative here are not natural as opposed to artificial means, but those means that 
offer a reasonable hope of benefit in regard to cure and return to health. Excessive burdens 
in terms of financial costs or inconvenience of lifestyle are measured by “the semi-objective 
standard of the common person regularly considered,” or what we refer to as the 
“reasonable person standard.”37  If the means used to prolong life were ineffective, if the 
effect was doubtful, or if it involves a grave burden for the person in question, this means 
need not be morally obligatory. 
Prior to the development of modern anesthesia, surgical procedures, especially 
amputations, were quite painful. Domingo Soto (1494-1560) reasoned that surgery such as 
amputation of a limb, because of the excessive pain, ought to be considered categorically 
optional. He argued that such torture was beyond the limits that the “common man” ought 
to be obliged to suffer for the sake of one’s bodily health. Such surgery can make a beneficial 
surgery “morally impossible” to bear.38    Besides the question of pain, Soto also recognizes 
the role that emotions of fear and repugnance could play.39  Soto incorporates the dimension 
of optional versus obligatory, adding if a procedure or treatment was too painful or 
burdensome, it would be morally optional. 
In 1595, Domingo Bañez (1528-1604) was the first to articulate the terms “ordinary” and 
“extraordinary” as they regard obligatory and non-obligatory means of preserving life. He 
argued that if preserving life was reasonable it was obligatory but insisted that one is “not 
bound to extraordinary means but to common food and clothing, to common medicines, to 
certain common and ordinary pain; not, however, to certain extraordinary and horrible 
pain, nor to expenses which are extraordinary in proportion to the status of this man.”40  
One determined if a treatment or medical procedure was ordinary or extraordinary 
according to whether it was proportionate to one’s condition or state in life. “Thus, if 
something were very costly or burdensome or if it did not offer substantial benefit to the 
patient, there was no moral obligation to use it. This standard applied to even life-saving 
measures.”41 The Jesuit moralist Juan Cardinal De Lugo (1583-1660) confirms Bañez’s 
position when he wrote, “…he is not held to the extraordinary and difficult means . . . the 
‘bonum’ of his life is not of such great moment, however, that its conservation must be 
effected with extraordinary diligence. . .”42  De Lugo’s position, like that of the Dominican 
moralists, followed the tradition of the Church that states human life is a good but not an 
absolute good. As a relative good, one’s duty to preserve it is a limited duty. While a person 
has freedom over his or her life, one is never permitted to directly take one’s life. The issue 
becomes to what extent is one obligated to preserve one’s life. 
The traditional understanding of ordinary-extraordinary means remained basically 
unchallenged until the mid-1900s with the advent of advances in medicine and technology. 
How to apply the early distinction of ordinary-extraordinary means to issues like oxygen 
and feeding tubes, especially with permanently unconscious patients became hotly debated 
as early as the 1950s. Jesuit moralist Gerald Kelly was one of the first to examine this issue 
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critically. He defined ordinary means of preserving life as “all medicines, treatments, and 
operations, which offer a reasonable hope of benefit for the patient and which can be 
obtained and used without excessive expense, pain, or other inconvenience.” Extraordinary 
means would be “all medicines, treatments, and operations, which cannot be obtained or 
used without excessive expense, pain, or other inconvenience, or which, if used, would not 
offer a reasonable hope of benefit.”43  The distinctive element of Kelly’s interpretation is that 
it is a patient-centered, quality-of-life approach which is consistent with how the 16th-
century-Dominican moralists viewed this distinction. Kelly concludes that no person is 
morally obligated to use any means, and this would include natural or artificial means, that 
does not offer a reasonable hope of ameliorating the patient’s condition. To clarify this 
distinction, Kelly was asked if oxygen and intravenous feeding must be used to extend the 
life of a patient in a terminal coma. He replies: “I see no reason why even the most delicate 
professional standard should call for their [oxygen and intravenous for a patient in a 
terminal coma] use. In fact, it seems to me that, apart from very special circumstances, the 
artificial means not only need not but should not be used, once the coma is reasonably 
diagnosed as terminal. Their use creates expense and nervous strain without conferring any 
real benefit.”44  
Many believe that the most authoritative historical study on this topic was done by Daniel 
Cronin (who later became Archbishop of Hartford) in his 1958 doctoral dissertation at the 
Gregorian University in Rome entitled, “The Moral Law in Regard to the Ordinary and 
Extraordinary Means of Preserving Life.” After a review of over 50 moral theologians from 
Aquinas to those writing in the early 1950’s Cronin concludes that the Church’s teaching is 
consistent in its view: “Even natural means, such as taking of food and drink, can become 
optional if taking them requires great effort or if the hope of beneficial results (spes salutis) is 
not present.” For a patient whose condition is incurable, he writes, “even ordinary means, 
according to the general norm, have become extraordinary [morally dispensable] for the 
patient [so] the wishes of the patient, expressed or reasonably interpreted, must be 
obeyed.”45 The importance of Cronin’s position is that no means—even food and water—
can ever be classified as absolutely obligatory regardless of the patient’s condition. 
However, some moralists disputed this fact and claimed that food and water were 
absolutely ordinary and even tried to say that was what the tradition taught. 
On November 24, 1957, in a talk delivered to the International Congress of 
Anesthesiologists, Pope Pius XII gave papal approbation to the ordinary-extraordinary 
means tradition that dates back to De Vitoria.  
“Natural reason and Christian morals say that man (and whoever is entrusted with taking 
care of his fellow man) has the right and the duty in case of serious illness to take the 
necessary treatment for the preservation of life and health . . . But normally one is held to 
use only ordinary means—according to circumstances of persons, places, times and 
culture—that is to say, means that do not involve grave burden for oneself or another. A 
more strict obligation would be too burdensome for most men and would render the 
attainment of the higher, more important good too difficult. Life, health, and all temporal 
activities are in fact subordinated to spiritual ends. On the other hand, one is not forbidden 
to take more than the strictly necessary steps to preserve life and health, as long as he does 
not fail in some more serious duty.”46  
Pius XII upholds the traditional ordinary-extraordinary means distinction that “involves 
patient-centered judgments about the quality of life, which must take into account the 
usefulness of the treatment, one’s understanding about death and dying, and the 
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repugnance one may have toward one’s life after subjection to a particular medical 
treatment.”47 It is also important to note that Pius XII emphasized the importance of viewing 
the person holistically. In an address given to the International Union Against Cancer, in 
1956, Pius XII counseled that “before anything else, the doctor should consider the whole 
man, in the unity of his person, that is to say, not merely his physical condition but his 
psychological state as well as his spiritual and moral ideals and his place in history.”48  This 
statement reinforces the traditional understanding of not treating the physiological aspect of 
the body separate from the person. Benefits of a treatment can only be determined within 
the context of a person’s life.49  To preserve life at all cost is to risk idolatry and thus would 
lead a person away from the higher spiritual good which is eternal life. 
A contemporary understanding of the ordinary-extraordinary means distinction was given 
in the 1980 Congregation for the Doctrine of the Faiths’ Declaration on Euthanasia. The 
Declaration follows the tradition on the ordinary-extraordinary means distinction since the 
16th century, which is based on the effect of the treatment on the patient or those responsible 
for the care of the patient. The Declaration reminds us of the duty one has to care for one’s 
own life and to seek such care for others. But there are limits to this obligation. One needs to 
judge the means used by “studying the type of treatment to be used, its degree of 
complexity or risk, its cost and the possibilities of using it, and comparing these elements 
with the result that can be expected, taking into account the state of the sick person and his 
or her physical and moral resources.”50 The Declaration goes on to give four examples: 
patients are permitted to use experimental, advanced medical techniques, which may be a 
service to humanity; patients may interrupt treatments if they fall short of expectations; the 
refusal of a technique that is in use and carries a risk or is burdensome is not equivalent to 
suicide; finally, when death is imminent in spite of the means used, it is permitted in 
conscience to make the decision to refuse forms of treatment that would only secure a 
precarious and burdensome prolongation of life, so long as the normal care due to the sick 
person in similar cases is not interrupted.51 Finally, the Congregation for the Doctrine of the 
Faith reflects the traditional teaching when it writes: “Life is a gift from God, and on the 
other hand death is unavoidable; it is necessary, therefore, that we, without in any way 
hastening the hour of death, should be able to accept it with full responsibility and 
dignity.”52 The only real change is that the document realizes that the terms ordinary and 
extraordinary are imprecise as terms in regards to the rapid advancement of medicine and 
technology. More precise terms would be proportionate and disproportionate.53  
The historical review of the tradition shows a clear distinction between extraordinary and 
ordinary means that involves patient-centered judgments about the quality of life, which 
must take into account the usefulness of the treatment, one’s understanding about death and 
dying, and the repugnance one may have toward one’s life after subjection to a particular 
medical treatment.54 The ethical issue concerning frozen embryos focuses on the foregoing 
of artificial life support from them, which would allow the embryos to die naturally. Some 
might argue that this is a form of euthanasia. Pope John Paul II in Evangelium Vitae states: 
“Euthanasia’s terms of reference, therefore, are to be found in the intention of the will and in 
the methods used.”55 The intention here is not to end the life of the embryo but to forego a 
burdensome treatment and allow the embryo to die naturally with dignity and respect. The 
Pope himself states clearly that euthanasia must be distinguished from the decision to 
forego what he refers to as “aggressive medical treatment.” “Medical procedures which no 
longer correspond to the real situation of the patient, either because they are by now 
disproportionate to any expected results or because they impose an excessive burden on the 
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patient and his family.56 If the intentionality is to forego a non-beneficial treatment that the 
surrogate believes is disproportionate and not in the embryo’s best interest, then the 
intentionality is to allow the person to die rather than not to terminate the person directly. 
These embryos will not be abandoned or discarded. Instead they will be cared for lovingly 
during the dying process and treated with the utmost dignity and respect. 
The benefit of a medical procedure or treatment was traditionally viewed as a prudential 
judgment of the patient or surrogate on how a particular treatment or procedure would 
impact on the life of the patient. Benefits and burdens were never judged abstractly. “Not 
only the means (proposed intervention) but the ends toward which the intervention is 
aimed are important in moral analysis.”57 The fact that a particular means was able to 
sustain a human life did not make such a means beneficial to the person. Traditional 
moralists did not restrict benefits merely to sustaining life, but included broader, more 
holistic considerations. Improvements in one’s condition, relief of pain and suffering, 
maximization of comfort, restoration of health, among others all were considered beneficial. 
For DeVitoria and other traditional moralists, the mere preservation of life and vital 
physiological functions was not sufficient in itself to oblige someone to use a certain means. 
The traditional understanding of ordinary-extraordinary means was based on treating the 
whole person, not one part of the person. Just because a treatment could prolong a life did 
not mean that a particular treatment was a benefit. Benefits must be considered worthwhile 
both in quality and duration. In the Catholic moral tradition, a medical treatment was 
beneficial if it restored a patient to a relative state of health. The frozen embryos will not be 
implanted into the womb of the biological mother. The options would be to stay frozen in a 
state of “permanent suspended animation,” be used for stem cell research, be used for other 
forms of experimentation, or be placed for donation/adoption. The Magisterium of the 
Catholic Church has rejected all of these options as ethically acceptable. To allow these 
embryos to stay frozen indefinitely violates the basic dignity and respect of the person. 
Therefore, the only viable option for these frozen embryos would be to stop the process of 
cryopreservation and allow them to die naturally with dignity and respect. One could 
equate the process of cryopreservation to maintain the life of the embryo to the use of a 
mechanical ventilator to maintain the life of a terminal patient. To continue to keep the 
embryos alive through cryopreservation is a form of extraordinary means that is 
disproportionate and offers no reasonable hope of benefit for the embryo. Failure to receive 
a meaningful benefit from a treatment makes said treatment not morally obligatory. 
Allowing a person to die by foregoing aggressive, non-beneficial treatments is not only 
morally permissible, it is also treating the person with dignity and respect. Therefore, it is 
morally and ethically acceptable to allow these embryos to die naturally with dignity and 
respect under the principle of the extraordinary and ordinary means distinction. However, it 
is also imperative that safeguards be put in place that would eliminate creating more 
“spare” embryos in the future.  
4. Conclusion & safeguards 
Cryopreserved embryos are a complex issue that has medical, legal and ethical dimensions. 
Allowing these embryos to die naturally is the only viable option that protects and preserves 
their human dignity. The other viable options: being discarded, destroyed for research, 
abandoned or kept in “suspended animation” indefinitely, are unacceptable because they have 
the potential of harming or intentionally killing these embryos that deserve special respect.  
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To make sure that this situation does not continue in the future, the following 
recommendations and safeguards are proposed: 
1. Only the number of eggs to be placed in the uterus of the mother will be fertilized. 
Embryos must not be subjected to an intentional interruption of their natural growth 
and development. There will no longer be “spare” embryos subjected to 
cryopreservation. Only cryopreservation of gametes would be acceptable. 
2. Laws and legislation must be enacted at the federal level that begins to regulate 
Assisted Reproductive Technologies. Having each state governed by differing sets of 
legislation could cause potential complications associated with the practice of 
donation/adoption. How each state defines jurisdiction and how each state interprets at 
what stage jurisdiction would begin (conception, transfer, or birth) could become highly 
complex. Specifically, guidelines and safeguards must be put in place that protects 
donors, parents, providers, and children born of ART. 
3. Laws and legislation must be enacted that regulates the creation, destruction and 
exploitation of human embryos. An example would be the following: legislation 
established in New Mexico stating that human embryos can only be disposed of 
through implantation, not intentional destruction or through destructive human 
embryo research. b) Embryos must not be subjected to non-therapeutic 
experimentation. 
If we believe that human life deserves dignity and respect, then our failure to allow these 
embryos to die naturally would be medically irresponsible and ethically objectionable, from 
the Catholic perspective. 
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